Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IPa-Gastric trial
NL-OMON60520Phase 3Recruiting
- Sponsor
- Karolinska University Hospital
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of paclitaxel in gastric cancer (GC) and gastroesophageal junction adenocarcinoma (2 arms), sponsored by Karolinska University Hospital. Primary endpoint: Overall survival. Started Aug 2026; status: recruiting.
02
Drugs
paclitaxel
03
Conditions
gastric cancer (GC)gastroesophageal junction adenocarcinoma
Beyond the preview
Go deeper on NL-OMON60520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON60520.